These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23385421)

  • 1. Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas.
    Holczbauer Á; Gyöngyösi B; Lotz G; Szijártó A; Kupcsulik P; Schaff Z; Kiss A
    J Histochem Cytochem; 2013 Apr; 61(4):294-305. PubMed ID: 23385421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
    Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
    Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas.
    Lódi C; Szabó E; Holczbauer A; Batmunkh E; Szíjártó A; Kupcsulik P; Kovalszky I; Paku S; Illyés G; Kiss A; Schaff Z
    Mod Pathol; 2006 Mar; 19(3):460-9. PubMed ID: 16439986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
    Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
    In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.
    Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Straub BK; Schirmacher P; Kovalszky I; Lotz G; Kiss A; Schaff Z
    Virchows Arch; 2011 Jun; 458(6):679-88. PubMed ID: 21503766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of claudin-1 and claudin-7 in liver cirrhosis and hepatocellular carcinoma.
    Holczbauer Á; Gyöngyösi B; Lotz G; Törzsök P; Kaposi-Novák P; Szijártó A; Tátrai P; Kupcsulik P; Schaff Z; Kiss A
    Pathol Oncol Res; 2014 Jul; 20(3):493-502. PubMed ID: 24696415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
    Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
    World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of claudin 1, claudin 4, and claudin 7 in colorectal cancer and its relation with CLDN DNA methylation patterns.
    Hahn-Strömberg V; Askari S; Ahmad A; Befekadu R; Nilsson TK
    Tumour Biol; 2017 Apr; 39(4):1010428317697569. PubMed ID: 28381183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.
    Li WT; Jeng YM; Yang CY
    Am J Surg Pathol; 2020 Dec; 44(12):1643-1648. PubMed ID: 32925194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
    Määttä M; Soini Y; Liakka A; Autio-Harmainen H
    Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.
    Ono Y; Hiratsuka Y; Murata M; Takasawa A; Fukuda R; Nojima M; Tanaka S; Osanai M; Hirata K; Sawada N
    Virchows Arch; 2016 Oct; 469(4):417-26. PubMed ID: 27444172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
    Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
    Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.
    Huang GW; Ding X; Chen SL; Zeng L
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1213-8. PubMed ID: 21647678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern.
    Tabariès S; Annis MG; Lazaris A; Petrillo SK; Huxham J; Abdellatif A; Palmieri V; Chabot J; Johnson RM; Van Laere S; Verhoef C; Hachem Y; Yumeen S; Meti N; Omeroglu A; Altinel G; Gao ZH; Yu ASL; Grünhagen DJ; Vermeulen P; Metrakos P; Siegel PM
    Commun Biol; 2021 Jun; 4(1):657. PubMed ID: 34079064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-7 expression in hepatocellular carcinoma.
    Brokalaki EI; Weber F; Sotiropoulos GC; Daoudaki M; Cicinnati VR; Beckebaum S
    Transplant Proc; 2012 Nov; 44(9):2737-40. PubMed ID: 23146509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker.
    Yang J; Liu X; Yuan X; Wang Z
    Oncol Rep; 2015 Sep; 34(3):1415-23. PubMed ID: 26134929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas.
    Aung PP; Mitani Y; Sanada Y; Nakayama H; Matsusaki K; Yasui W
    Virchows Arch; 2006 Apr; 448(4):428-34. PubMed ID: 16328347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12.
    Gröne J; Weber B; Staub E; Heinze M; Klaman I; Pilarsky C; Hermann K; Castanos-Velez E; Röpcke S; Mann B; Rosenthal A; Buhr HJ
    Int J Colorectal Dis; 2007 Jun; 22(6):651-9. PubMed ID: 17047970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma.
    Cheung ST; Leung KL; Ip YC; Chen X; Fong DY; Ng IO; Fan ST; So S
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):551-6. PubMed ID: 15701840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different expression of occludin and ZO-1 in primary and metastatic liver tumors.
    Orbán E; Szabó E; Lotz G; Kupcsulik P; Páska C; Schaff Z; Kiss A
    Pathol Oncol Res; 2008 Sep; 14(3):299-306. PubMed ID: 18386163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.